Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae-Reference-Cited by-同舟云学术

Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae

Published:2019-11-12 Issue:1 Volume:32 Page:15-20
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Önal Uğur¹,Sipahi Oğuz Reşat¹,Pullukçu Hüsnü¹,Yamazhan Tansu¹,Arda Bilgin¹,Ulusoy Sercan¹,Aydemir Şöhret²,Taşbakan Meltem Işıkgöz¹

Affiliation:

1. Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey;

2. Department of Microbiology, Faculty of Medicine, Ege University, Izmir, Turkey

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2019.1688490

Reference25 articles.

1. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe

2. European Union, European Union bEuropean Centre for Disease Prevention and Control (2012). Antimicrobial resistance surveillance in Europe 2011. Luxembourg, Publications Office of the European Union. Available from: http://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2011. Accessed: 26 February 2019.

3. An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes

4. Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City

5. Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salgın bizim işimiz: Karbapenem dirençli Enterobacteriaceae salgın yönetimi;Ege Tıp Dergisi;2024-06-10

2. Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases;European Journal of Clinical Microbiology & Infectious Diseases;2023-09-07

3. Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections;Expert Review of Anti-infective Therapy;2022-09-28

4. Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies;Scientific Reports;2022-03-09

5. The effect of double-carbapenem therapy on mortality rates and microbiological cure rates in patients diagnosed with carbapenem-resistant Klebsiella pneumoniae infections in comparison to monotherapy and currently used combinations of antibiotics;Journal of Medical Research and Innovation;2021-02-10